Concepts (243)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microglia | 17 | 2022 | 208 | 2.270 |
Why?
|
| Central Nervous System | 9 | 2015 | 152 | 1.570 |
Why?
|
| Receptors, Immunologic | 5 | 2011 | 73 | 1.160 |
Why?
|
| Membrane Glycoproteins | 5 | 2011 | 224 | 1.070 |
Why?
|
| Macrophages | 9 | 2018 | 529 | 0.970 |
Why?
|
| Lipopolysaccharides | 5 | 2015 | 239 | 0.730 |
Why?
|
| T-Lymphocytes | 5 | 2021 | 386 | 0.710 |
Why?
|
| Central Nervous System Infections | 2 | 2013 | 4 | 0.600 |
Why?
|
| Brain | 11 | 2021 | 1472 | 0.600 |
Why?
|
| Toxoplasma | 3 | 2021 | 12 | 0.590 |
Why?
|
| Chemokine CCL21 | 5 | 2021 | 14 | 0.570 |
Why?
|
| Interferon-gamma | 6 | 2011 | 269 | 0.540 |
Why?
|
| Neuroglia | 3 | 2013 | 133 | 0.530 |
Why?
|
| Mice | 25 | 2021 | 6644 | 0.530 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2010 | 279 | 0.510 |
Why?
|
| Toxoplasmosis, Cerebral | 2 | 2021 | 9 | 0.510 |
Why?
|
| Disease Models, Animal | 8 | 2021 | 1596 | 0.500 |
Why?
|
| Head Injuries, Closed | 1 | 2016 | 2 | 0.480 |
Why?
|
| Animals | 34 | 2025 | 16992 | 0.480 |
Why?
|
| Central Nervous System Diseases | 2 | 2007 | 32 | 0.470 |
Why?
|
| Cytokines | 3 | 2017 | 678 | 0.470 |
Why?
|
| Mice, Inbred C57BL | 14 | 2018 | 1869 | 0.460 |
Why?
|
| Immune System | 2 | 2007 | 41 | 0.440 |
Why?
|
| Lymphocyte Activation | 2 | 2013 | 249 | 0.440 |
Why?
|
| Cell Transplantation | 1 | 2013 | 4 | 0.410 |
Why?
|
| Monocytes | 1 | 2015 | 277 | 0.400 |
Why?
|
| Epilepsy | 1 | 2013 | 59 | 0.390 |
Why?
|
| Chemotaxis | 1 | 2013 | 68 | 0.380 |
Why?
|
| Nerve Tissue Proteins | 2 | 2007 | 386 | 0.380 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 587 | 0.370 |
Why?
|
| Chemokines | 1 | 2013 | 96 | 0.370 |
Why?
|
| Ornithine Decarboxylase | 1 | 2011 | 10 | 0.340 |
Why?
|
| Putrescine | 1 | 2011 | 27 | 0.340 |
Why?
|
| Immunotherapy, Active | 1 | 2010 | 3 | 0.330 |
Why?
|
| Chemokine CCL2 | 2 | 2011 | 95 | 0.330 |
Why?
|
| Alzheimer Disease | 3 | 2017 | 1001 | 0.330 |
Why?
|
| Amyloid | 1 | 2010 | 65 | 0.310 |
Why?
|
| Macrophage Activation | 1 | 2009 | 61 | 0.290 |
Why?
|
| Cells, Cultured | 6 | 2017 | 1621 | 0.290 |
Why?
|
| Encephalitis | 2 | 2006 | 43 | 0.280 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 2 | 2007 | 55 | 0.280 |
Why?
|
| Gene Expression Regulation | 4 | 2021 | 1070 | 0.270 |
Why?
|
| Mice, Transgenic | 5 | 2016 | 665 | 0.270 |
Why?
|
| Autoimmune Diseases | 2 | 2007 | 65 | 0.270 |
Why?
|
| Neuroimmunomodulation | 1 | 2007 | 12 | 0.260 |
Why?
|
| RNA, Messenger | 4 | 2018 | 1271 | 0.250 |
Why?
|
| Gene Expression | 2 | 2009 | 701 | 0.250 |
Why?
|
| Blotting, Northern | 4 | 2010 | 150 | 0.250 |
Why?
|
| Immune Tolerance | 1 | 2006 | 68 | 0.250 |
Why?
|
| Gliosis | 1 | 2006 | 25 | 0.250 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2008 | 213 | 0.250 |
Why?
|
| Brain Diseases | 1 | 2006 | 31 | 0.240 |
Why?
|
| Multiple Sclerosis | 2 | 2006 | 50 | 0.240 |
Why?
|
| Hazardous Substances | 1 | 2025 | 19 | 0.240 |
Why?
|
| Neurotoxins | 1 | 2025 | 57 | 0.230 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2025 | 38 | 0.230 |
Why?
|
| Immunity, Innate | 2 | 2018 | 171 | 0.230 |
Why?
|
| In Situ Hybridization | 4 | 2010 | 138 | 0.220 |
Why?
|
| Neuritis | 1 | 2003 | 2 | 0.210 |
Why?
|
| Pneumonia | 2 | 2018 | 61 | 0.200 |
Why?
|
| Killer Cells, Natural | 1 | 2003 | 104 | 0.190 |
Why?
|
| Transcription Factors | 1 | 2007 | 735 | 0.190 |
Why?
|
| Humans | 20 | 2025 | 43102 | 0.190 |
Why?
|
| Mice, Knockout | 8 | 2021 | 1035 | 0.180 |
Why?
|
| Astrocytes | 4 | 2015 | 244 | 0.170 |
Why?
|
| Osteonectin | 1 | 2021 | 10 | 0.170 |
Why?
|
| Antigen Presentation | 3 | 2006 | 58 | 0.160 |
Why?
|
| Extracellular Matrix | 1 | 2021 | 131 | 0.160 |
Why?
|
| Biomedical Research | 2 | 2021 | 502 | 0.160 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 652 | 0.150 |
Why?
|
| Spine | 1 | 2018 | 14 | 0.140 |
Why?
|
| Obesity | 2 | 2018 | 1151 | 0.140 |
Why?
|
| Hypothalamus | 1 | 2018 | 120 | 0.140 |
Why?
|
| Brain Stem | 1 | 2018 | 52 | 0.130 |
Why?
|
| Inflammation | 3 | 2015 | 758 | 0.130 |
Why?
|
| Allergens | 1 | 2018 | 65 | 0.130 |
Why?
|
| Congresses as Topic | 1 | 2017 | 50 | 0.130 |
Why?
|
| Demyelinating Diseases | 2 | 2007 | 14 | 0.130 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2017 | 47 | 0.130 |
Why?
|
| Fungi | 1 | 2018 | 106 | 0.130 |
Why?
|
| Sex Characteristics | 1 | 2018 | 258 | 0.120 |
Why?
|
| Receptors, CCR7 | 2 | 2021 | 19 | 0.120 |
Why?
|
| Inservice Training | 1 | 2015 | 33 | 0.120 |
Why?
|
| Minority Groups | 1 | 2021 | 690 | 0.110 |
Why?
|
| Interpersonal Relations | 1 | 2017 | 222 | 0.110 |
Why?
|
| Microscopy, Confocal | 1 | 2016 | 224 | 0.110 |
Why?
|
| Adipokines | 1 | 2015 | 28 | 0.110 |
Why?
|
| Catecholamines | 1 | 2015 | 45 | 0.110 |
Why?
|
| Signal Transduction | 3 | 2013 | 2157 | 0.110 |
Why?
|
| Nerve Degeneration | 2 | 2006 | 111 | 0.110 |
Why?
|
| Phagocytosis | 2 | 2015 | 86 | 0.110 |
Why?
|
| Neurons | 3 | 2021 | 1263 | 0.110 |
Why?
|
| Bone Marrow Transplantation | 2 | 2012 | 19 | 0.100 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2015 | 146 | 0.100 |
Why?
|
| Inflammation Mediators | 1 | 2015 | 140 | 0.100 |
Why?
|
| Brain Injuries | 1 | 2015 | 129 | 0.100 |
Why?
|
| Succinimides | 1 | 2013 | 12 | 0.100 |
Why?
|
| Fluoresceins | 1 | 2013 | 29 | 0.100 |
Why?
|
| Interleukin-10 | 2 | 2018 | 87 | 0.100 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2013 | 18 | 0.100 |
Why?
|
| Chemokine CCL19 | 2 | 2010 | 10 | 0.090 |
Why?
|
| Autoimmune Diseases of the Nervous System | 1 | 2012 | 3 | 0.090 |
Why?
|
| Huntington Disease | 1 | 2012 | 31 | 0.090 |
Why?
|
| Fluorescent Dyes | 1 | 2013 | 182 | 0.090 |
Why?
|
| Bone Marrow Cells | 1 | 2012 | 79 | 0.090 |
Why?
|
| Flow Cytometry | 1 | 2013 | 411 | 0.090 |
Why?
|
| Spermidine | 1 | 2011 | 34 | 0.080 |
Why?
|
| Injections, Intraventricular | 1 | 2011 | 59 | 0.080 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2010 | 25 | 0.080 |
Why?
|
| Spermine | 1 | 2011 | 67 | 0.080 |
Why?
|
| Cell Line, Transformed | 1 | 2010 | 95 | 0.080 |
Why?
|
| Time Factors | 2 | 2013 | 1857 | 0.080 |
Why?
|
| Toxoplasmosis | 1 | 2010 | 4 | 0.080 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2010 | 15 | 0.080 |
Why?
|
| Cerebellum | 1 | 2010 | 79 | 0.080 |
Why?
|
| RNA | 2 | 2009 | 266 | 0.080 |
Why?
|
| Antidepressive Agents | 1 | 2010 | 65 | 0.080 |
Why?
|
| Amino Acid Sequence | 2 | 2002 | 1180 | 0.080 |
Why?
|
| Antigen-Presenting Cells | 2 | 2006 | 31 | 0.080 |
Why?
|
| Reverse Transcription | 1 | 2009 | 23 | 0.080 |
Why?
|
| Lymphotoxin-beta | 1 | 2009 | 2 | 0.080 |
Why?
|
| Molecular Sequence Data | 2 | 2002 | 1542 | 0.080 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2009 | 15 | 0.070 |
Why?
|
| Male | 6 | 2018 | 23409 | 0.070 |
Why?
|
| Gene Expression Profiling | 2 | 2010 | 704 | 0.070 |
Why?
|
| Heredodegenerative Disorders, Nervous System | 1 | 2008 | 2 | 0.070 |
Why?
|
| Dendritic Cells | 1 | 2009 | 132 | 0.070 |
Why?
|
| Bone Diseases | 1 | 2008 | 18 | 0.070 |
Why?
|
| Dementia, Vascular | 1 | 2008 | 35 | 0.070 |
Why?
|
| Models, Neurological | 1 | 2009 | 136 | 0.070 |
Why?
|
| Lymphotoxin beta Receptor | 1 | 2007 | 5 | 0.070 |
Why?
|
| Acute Disease | 1 | 2007 | 155 | 0.070 |
Why?
|
| Interleukin-17 | 1 | 2007 | 53 | 0.060 |
Why?
|
| Myelin Sheath | 2 | 2007 | 46 | 0.060 |
Why?
|
| Chemokines, CXC | 2 | 2007 | 36 | 0.060 |
Why?
|
| Cell Count | 2 | 2007 | 145 | 0.060 |
Why?
|
| Computational Biology | 1 | 2009 | 327 | 0.060 |
Why?
|
| Cell Proliferation | 1 | 2013 | 1455 | 0.060 |
Why?
|
| Cell Death | 2 | 2006 | 278 | 0.060 |
Why?
|
| Colitis | 1 | 2007 | 71 | 0.060 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2008 | 300 | 0.060 |
Why?
|
| Autoimmunity | 1 | 2006 | 58 | 0.060 |
Why?
|
| AIDS Dementia Complex | 1 | 2006 | 116 | 0.060 |
Why?
|
| Neurodegenerative Diseases | 1 | 2007 | 141 | 0.060 |
Why?
|
| Rats | 2 | 2003 | 3735 | 0.060 |
Why?
|
| Immunotherapy | 1 | 2006 | 144 | 0.060 |
Why?
|
| Cooperative Behavior | 1 | 2006 | 269 | 0.050 |
Why?
|
| Cell Compartmentation | 1 | 2004 | 12 | 0.050 |
Why?
|
| Cytoprotection | 1 | 2004 | 36 | 0.050 |
Why?
|
| Motor Neurons | 1 | 2004 | 90 | 0.050 |
Why?
|
| Cell Survival | 2 | 2004 | 945 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2006 | 536 | 0.050 |
Why?
|
| Macrophages, Peritoneal | 1 | 2002 | 23 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2025 | 863 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2002 | 139 | 0.050 |
Why?
|
| Cloning, Molecular | 1 | 2002 | 314 | 0.050 |
Why?
|
| Lymphocytes | 1 | 2002 | 124 | 0.050 |
Why?
|
| Leukocytes | 1 | 2002 | 80 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 1 | 2002 | 423 | 0.040 |
Why?
|
| Chromosome Mapping | 1 | 2002 | 199 | 0.040 |
Why?
|
| DNA, Complementary | 1 | 2002 | 196 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2002 | 240 | 0.040 |
Why?
|
| Ovary | 1 | 2002 | 113 | 0.040 |
Why?
|
| Maryland | 1 | 2021 | 66 | 0.040 |
Why?
|
| Base Sequence | 1 | 2002 | 983 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2002 | 456 | 0.040 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2021 | 60 | 0.040 |
Why?
|
| Antigens, Protozoan | 1 | 2021 | 74 | 0.040 |
Why?
|
| Testis | 1 | 2002 | 207 | 0.040 |
Why?
|
| Host-Parasite Interactions | 1 | 2021 | 79 | 0.040 |
Why?
|
| Immunization | 2 | 2015 | 94 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 1 | 2002 | 515 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 2002 | 383 | 0.040 |
Why?
|
| Stress, Psychological | 1 | 2006 | 661 | 0.040 |
Why?
|
| Research Personnel | 1 | 2021 | 206 | 0.040 |
Why?
|
| Substance-Related Disorders | 1 | 2006 | 830 | 0.040 |
Why?
|
| Female | 5 | 2018 | 24698 | 0.040 |
Why?
|
| Fertility | 1 | 2018 | 62 | 0.040 |
Why?
|
| Hippocampus | 1 | 2002 | 594 | 0.030 |
Why?
|
| Arginase | 1 | 2018 | 15 | 0.030 |
Why?
|
| Dietary Fats | 1 | 2018 | 117 | 0.030 |
Why?
|
| Inhalation Exposure | 1 | 2018 | 44 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2018 | 127 | 0.030 |
Why?
|
| Protein Binding | 1 | 2021 | 1082 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2018 | 128 | 0.030 |
Why?
|
| Allergy and Immunology | 1 | 2017 | 14 | 0.030 |
Why?
|
| Speech | 1 | 2017 | 16 | 0.030 |
Why?
|
| Cuprizone | 2 | 2007 | 5 | 0.030 |
Why?
|
| Cell Movement | 1 | 2021 | 655 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2018 | 165 | 0.030 |
Why?
|
| Corpus Callosum | 2 | 2007 | 14 | 0.030 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2017 | 95 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2002 | 1766 | 0.030 |
Why?
|
| Nootropic Agents | 1 | 2015 | 7 | 0.030 |
Why?
|
| Resistin | 1 | 2015 | 4 | 0.030 |
Why?
|
| Locus Coeruleus | 1 | 2015 | 17 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 2 | 2009 | 694 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2017 | 307 | 0.030 |
Why?
|
| Thermogenesis | 1 | 2015 | 26 | 0.030 |
Why?
|
| Hormones | 1 | 2015 | 55 | 0.030 |
Why?
|
| Chemokine CXCL10 | 2 | 2007 | 38 | 0.030 |
Why?
|
| Lipoproteins | 1 | 2015 | 70 | 0.030 |
Why?
|
| Biological Transport | 1 | 2015 | 204 | 0.030 |
Why?
|
| Protein Folding | 1 | 2015 | 123 | 0.030 |
Why?
|
| Neural Pathways | 1 | 2015 | 138 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2015 | 259 | 0.020 |
Why?
|
| Disease Progression | 1 | 2015 | 667 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 719 | 0.020 |
Why?
|
| Adoptive Transfer | 1 | 2010 | 53 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2009 | 48 | 0.020 |
Why?
|
| Ovalbumin | 1 | 2009 | 47 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2009 | 83 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2010 | 368 | 0.020 |
Why?
|
| Apoptosis | 2 | 2007 | 1568 | 0.020 |
Why?
|
| Tumor Necrosis Factor Ligand Superfamily Member 14 | 1 | 2007 | 3 | 0.020 |
Why?
|
| Oligodendroglia | 1 | 2007 | 27 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2007 | 80 | 0.020 |
Why?
|
| HT29 Cells | 1 | 2007 | 60 | 0.020 |
Why?
|
| Sulfhydryl Compounds | 1 | 2007 | 51 | 0.020 |
Why?
|
| Th1 Cells | 1 | 2007 | 97 | 0.020 |
Why?
|
| PPAR alpha | 1 | 2007 | 42 | 0.020 |
Why?
|
| Lung | 1 | 2010 | 492 | 0.020 |
Why?
|
| Liver | 1 | 2010 | 511 | 0.020 |
Why?
|
| Thiazoles | 1 | 2007 | 76 | 0.020 |
Why?
|
| Cell Division | 1 | 2007 | 311 | 0.020 |
Why?
|
| Spleen | 1 | 2007 | 204 | 0.020 |
Why?
|
| Risk Factors | 1 | 2015 | 3994 | 0.020 |
Why?
|
| Crohn Disease | 1 | 2007 | 71 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2007 | 296 | 0.020 |
Why?
|
| Cell Line | 1 | 2010 | 1410 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2007 | 259 | 0.020 |
Why?
|
| Phenols | 1 | 2007 | 107 | 0.010 |
Why?
|
| Chelating Agents | 1 | 2006 | 52 | 0.010 |
Why?
|
| Radiation Chimera | 1 | 2004 | 8 | 0.010 |
Why?
|
| Axotomy | 1 | 2004 | 17 | 0.010 |
Why?
|
| Facial Nerve | 1 | 2004 | 11 | 0.010 |
Why?
|
| Genes, MHC Class II | 1 | 2004 | 21 | 0.010 |
Why?
|
| Antigens | 1 | 2004 | 59 | 0.010 |
Why?
|
| Age Factors | 1 | 2007 | 1154 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 934 | 0.010 |
Why?
|
| Receptors, CXCR3 | 1 | 2002 | 31 | 0.010 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2002 | 75 | 0.010 |
Why?
|
| Receptors, Chemokine | 1 | 2002 | 72 | 0.010 |
Why?
|